KE

17.9202.71%
MA

Michele A. M. Holcomb

Independent Director

Dr. Michele A. M. Holcomb, Ph.D., is Advisory Trustee of Liberty Science Center, Inc. Dr. Holcomb is Independent Director of Compugen Ltd. from February 11, 2026. She is Director of Controlant hf. from June 2025. She is Independent Director of Kimball Electronics Indiana, Inc. from 2019. Dr. Holcomb serves as Independent Non-Executive Director of PureTech Health plc since September 2024. She is a Director at Vineti, Inc. since June 2020. Dr. Holcomb served as Chief Strategy and Business Development Officer of Cardinal Health, Inc. since January 2017 until September 2022 and served as its Executive Vice President of Strategy and Corporate Development since January 2017. Dr. Holcomb joined Cardinal Health from Teva Pharmaceutical Industries Ltd., where she served as Senior Vice President of Strategy, Portfolio, Search and Partnerships and Chief Operating Officer, Global R&D from October 2015 to December 2016, Senior Vice President, Chief Operating Officer, Global R&D from September 2012 to September 2015 and Vice President of Corporate Strategy and Operational Planning from April 2010 to September 2012. She serves as Independent Director of Kimball Electronics, Inc. since November 7, 2019. She also serves on the board of the Abigail Wexner Research Institute at Nationwide Children's Hospital in Columbus, the BalletMet of Columbus, where she chairs the long-range planning committee and the Liberty Science Center in New Jersey. Dr. Holcomb is a member of the editorial advisory board of Pharmaceutical Executive and has lectured on healthcare strategy at Kellogg (Northwestern), Columbia and Fuqua (Duke) business schools. Dr. Holcomb received a BS in chemistry from Stanford University and a PhD in chemistry from the University of California, Berkeley and previously worked as an R&D chemist at Ciba-Geigy and Syntex Pharmaceuticals.

Positions